AR073901A1 - Composicion topica farmaceutica, unguento y cremas que la comprende, y sus usos - Google Patents
Composicion topica farmaceutica, unguento y cremas que la comprende, y sus usosInfo
- Publication number
- AR073901A1 AR073901A1 ARP090104005A ARP090104005A AR073901A1 AR 073901 A1 AR073901 A1 AR 073901A1 AR P090104005 A ARP090104005 A AR P090104005A AR P090104005 A ARP090104005 A AR P090104005A AR 073901 A1 AR073901 A1 AR 073901A1
- Authority
- AR
- Argentina
- Prior art keywords
- cream
- incorporations
- cream according
- components
- surfactants
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Reivindicacion 1: Una composicion farmacéutica topica semisolida y estable, caracterizada porque comprende entre 0,2 y 5% de la composicion de ozenoxacino, y un vehículo adecuado para elaborar un ungüento o una crema. Reivindicacion 4: Un ungüento conforme a la reivindicacion 3, caracterizado porque el vehículo adecuado es la parafina blanda blanca. Reivindicacion 6: Una crema conforme a la reivindicacion 5, caracterizada porque el vehículo incluye, en las proporciones consignadas a continuacion, como componentes de la crema: emulsificadores: 15-25%; preferentemente 18-22%; en particular 20%; surfactantes: 10-20%; preferentemente 13-15%; en particular 14%; componentes de aceite: 5-15%; preferentemente 7-9%; en particular 8%; ceras de bajo punto de fusion: 1-10%; preferiblemente 3-5%; en particular 4%; agua: 30-45%; preferentemente 35-40%; en particular 37,9%; componentes dispersables en agua: 10-20%; preferentemente 13-17%; en particular 15%; y conservantes que no donan formaldehído: 0,01-1% preferentemente 0,05-0,15%; en particular 0,1%. Reivindicacion 8: Una crema conforme a cualquiera de las incorporaciones 5 a 7, caracterizada porque los surfactantes son glicéridos poliglicolizados de ácidos oleicos. Reivindicacion 9: Una crema conforme a cualquiera de las incorporaciones 5 a 8, caracterizada porque el componente de aceite es el dodecanol 2-octil alcohol Guerbet. Reivindicacion 12: Una crema conforme a cualquiera de las incorporaciones 5 a 11, caracterizada porque el conservante que no dona formaldehído es el ácido benzoico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08166933A EP2177208A1 (en) | 2008-10-17 | 2008-10-17 | Pharmaceutical topical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AR073901A1 true AR073901A1 (es) | 2010-12-09 |
Family
ID=40291273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090104005A AR073901A1 (es) | 2008-10-17 | 2009-10-19 | Composicion topica farmaceutica, unguento y cremas que la comprende, y sus usos |
Country Status (24)
Country | Link |
---|---|
US (4) | US9180200B2 (es) |
EP (3) | EP2177208A1 (es) |
JP (2) | JP5509209B2 (es) |
KR (3) | KR20160025034A (es) |
CN (1) | CN102186460B (es) |
AR (1) | AR073901A1 (es) |
AU (1) | AU2009305360B2 (es) |
BR (1) | BRPI0920355B8 (es) |
CA (2) | CA2738384C (es) |
CL (2) | CL2011000848A1 (es) |
CY (1) | CY1114838T1 (es) |
DK (1) | DK2344130T3 (es) |
ES (1) | ES2437967T3 (es) |
HK (1) | HK1161552A1 (es) |
MX (2) | MX338029B (es) |
NL (1) | NL300884I2 (es) |
PH (1) | PH12014502425A1 (es) |
PL (1) | PL2344130T3 (es) |
PT (1) | PT2344130E (es) |
RU (1) | RU2478367C2 (es) |
SI (1) | SI2344130T1 (es) |
TW (2) | TW201511779A (es) |
UY (1) | UY32187A (es) |
WO (1) | WO2010043717A2 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130102460A (ko) * | 2010-05-10 | 2013-09-17 | 세게티스, 인코포레이티드. | 알킬 케탈 에스터를 함유하는 퍼스널 케어 조제물 및 제조방법 |
WO2014047428A1 (en) | 2012-09-21 | 2014-03-27 | Segetis, Inc. | Cleaning, surfactant, and personal care compositions |
DE102013226507B4 (de) | 2013-12-18 | 2022-05-05 | Ashland Industries Europe Gmbh | Konzentrat umfassend Ferulasäureethylester und Arylalkanol und dessen Verwendung |
ES2970434T3 (es) | 2014-09-12 | 2024-05-28 | Union Therapeutics As | Uso antibacteriano de salicilanilidas halogenadas |
JP6775869B2 (ja) * | 2015-02-13 | 2020-10-28 | マルホ株式会社 | ピリドンカルボン酸系誘導体を含有する外用剤 |
GB201509326D0 (en) | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
GB201604484D0 (en) | 2016-03-16 | 2016-04-27 | Antibiotx Aps And Københavns Uni University Of Copenhagen | Topical antibacterial compositions |
JP7347915B2 (ja) * | 2016-04-28 | 2023-09-20 | マルホ株式会社 | 抗菌剤 |
WO2018048042A1 (ko) * | 2016-09-12 | 2018-03-15 | 주식회사 가나씨앤에이치 | 글리세린 젖산 에스테르를 유효성분으로 하는 방부 및 항균용 외용제 조성물 |
CN110035755A (zh) * | 2016-12-01 | 2019-07-19 | 玛路弘株式会社 | 医疗用皮肤外用剂 |
US11419834B2 (en) | 2019-02-25 | 2022-08-23 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide |
CN113712913A (zh) * | 2020-05-25 | 2021-11-30 | 南京帝昌医药科技有限公司 | 一种奥泽沙星混悬滴眼液组合物 |
US11724077B2 (en) * | 2021-07-28 | 2023-08-15 | Subhash Dhawan | Therapeutic swabs for treating upper respiratory infections |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04243827A (ja) * | 1991-01-25 | 1992-08-31 | Sumitomo Pharmaceut Co Ltd | プロスタグランジン誘導体含有溶解型軟膏剤 |
JP3174590B2 (ja) * | 1991-04-04 | 2001-06-11 | テルモ株式会社 | ステロイド軟膏剤 |
FR2728166A1 (fr) * | 1994-12-19 | 1996-06-21 | Oreal | Composition topique contenant un antagoniste de substance p |
JP3162335B2 (ja) * | 1998-03-11 | 2001-04-25 | ユーナイテッド ネイションズ デベロップメント プログラム | 皮膚真菌感染症治療用の植物薬剤、その製造法と用途 |
EP1070713B1 (en) | 1998-04-06 | 2006-10-18 | Toyama Chemical Co., Ltd. | Quinolonecarboxylic acid derivatives or salts thereof |
ES2233383T3 (es) * | 1999-06-08 | 2005-06-16 | Lorantis Limited | Utilizacion terapeutica de un ihibidor de la via de señalizacion hedgehog. |
JP4293755B2 (ja) | 2001-03-26 | 2009-07-08 | 富山化学工業株式会社 | ピリドンカルボン酸系化合物を含有する皮膚外用剤 |
JP4384402B2 (ja) | 2001-11-30 | 2009-12-16 | 富山化学工業株式会社 | デスフルオロピリドンカルボン酸系化合物を含有する水溶液剤およびその粉末化物並びにそれら製造方法 |
HUE028288T2 (en) | 2004-03-31 | 2016-12-28 | Toyama Chemical Co Ltd | A fine dispersion of a low solubility drug and a process for producing it |
EP1698336A1 (en) * | 2005-03-01 | 2006-09-06 | Ferrer Internacional, S.A. | Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent |
KR101245960B1 (ko) * | 2005-08-01 | 2013-03-21 | 마루호 코 엘티디 | 피리돈카르복시산 유도체를 함유하는 로션제 |
JP5112669B2 (ja) | 2005-09-30 | 2013-01-09 | 富山化学工業株式会社 | 難溶性薬物のナノ微粒子を含有する水性懸濁液剤 |
-
2008
- 2008-10-17 EP EP08166933A patent/EP2177208A1/en not_active Withdrawn
-
2009
- 2009-10-16 CA CA2738384A patent/CA2738384C/en active Active
- 2009-10-16 US US13/124,403 patent/US9180200B2/en active Active
- 2009-10-16 MX MX2013009409A patent/MX338029B/es unknown
- 2009-10-16 EP EP12192559A patent/EP2570117A1/en not_active Withdrawn
- 2009-10-16 SI SI200930749T patent/SI2344130T1/sl unknown
- 2009-10-16 KR KR1020167003529A patent/KR20160025034A/ko not_active Application Discontinuation
- 2009-10-16 MX MX2011004052A patent/MX2011004052A/es active IP Right Grant
- 2009-10-16 PL PL09736946T patent/PL2344130T3/pl unknown
- 2009-10-16 CN CN2009801408602A patent/CN102186460B/zh active Active
- 2009-10-16 PT PT97369466T patent/PT2344130E/pt unknown
- 2009-10-16 ES ES09736946.6T patent/ES2437967T3/es active Active
- 2009-10-16 CA CA2822167A patent/CA2822167C/en not_active Expired - Fee Related
- 2009-10-16 WO PCT/EP2009/063625 patent/WO2010043717A2/en active Application Filing
- 2009-10-16 RU RU2011119764/15A patent/RU2478367C2/ru active
- 2009-10-16 DK DK09736946.6T patent/DK2344130T3/da active
- 2009-10-16 KR KR1020117008243A patent/KR101682256B1/ko active IP Right Grant
- 2009-10-16 EP EP09736946.6A patent/EP2344130B9/en active Active
- 2009-10-16 BR BRPI0920355A patent/BRPI0920355B8/pt not_active IP Right Cessation
- 2009-10-16 AU AU2009305360A patent/AU2009305360B2/en not_active Ceased
- 2009-10-16 JP JP2011531512A patent/JP5509209B2/ja not_active Expired - Fee Related
- 2009-10-16 KR KR1020167026446A patent/KR20160116353A/ko not_active Application Discontinuation
- 2009-10-19 TW TW103134727A patent/TW201511779A/zh unknown
- 2009-10-19 AR ARP090104005A patent/AR073901A1/es unknown
- 2009-10-19 TW TW098135341A patent/TWI504418B/zh not_active IP Right Cessation
- 2009-10-19 UY UY0001032187A patent/UY32187A/es active IP Right Grant
-
2011
- 2011-04-15 CL CL2011000848A patent/CL2011000848A1/es unknown
-
2012
- 2012-02-24 HK HK12101885.2A patent/HK1161552A1/xx not_active IP Right Cessation
-
2013
- 2013-12-03 CY CY20131101082T patent/CY1114838T1/el unknown
-
2014
- 2014-02-21 JP JP2014031852A patent/JP5873120B2/ja not_active Expired - Fee Related
- 2014-03-05 US US14/197,933 patent/US9399014B2/en active Active
- 2014-10-29 PH PH12014502425A patent/PH12014502425A1/en unknown
-
2015
- 2015-09-29 CL CL2015002899A patent/CL2015002899A1/es unknown
- 2015-10-14 US US14/882,818 patent/US20160030338A1/en not_active Abandoned
-
2016
- 2016-05-04 US US15/146,461 patent/US10022363B2/en active Active
-
2017
- 2017-07-11 NL NL300884C patent/NL300884I2/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR073901A1 (es) | Composicion topica farmaceutica, unguento y cremas que la comprende, y sus usos | |
ES2524320T3 (es) | Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo | |
AR113034A2 (es) | Formulación líquida de un conjugado de la hormona del crecimiento humano de efecto prolongado | |
CO6220926A2 (es) | Formulacion farmaceutica topica para la aplicacion de un farmaco antiinflamatorio no esferoidal (nsaid) | |
AR051420A1 (es) | Procesos para la preparacion de composiciones oleosas | |
CY1120888T1 (el) | Διαδερμικες φαρμακευτικες συνθεσεις περιλαμβανοντας ενεργους παραγοντες | |
AR070122A1 (es) | Composicion de limpieza de bajos residuos | |
ECSP10010433A (es) | Composición que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes ácidas | |
PE20110449A1 (es) | Emulsiones modificadas de liberacion de medicina para aplicacion a la piel o la mucosa vaginal | |
NI201200038A (es) | Conjugados de niacina y ácidos grasos y sus usos | |
RU2010114233A (ru) | Применение гидрофобин-полипептидов в качестве усилителя пенетрации | |
PE20142367A1 (es) | Formulaciones de imiquimod | |
CO6270203A2 (es) | Una solucion topica no acuosa novedosa de diclofenaco y el proceso para preparar la misma | |
BRPI0912290A8 (pt) | Detergentes para pele e mãos. | |
CO6390034A2 (es) | Uso de una composición espumable esencialmente libre de ingredientes con actividad farmacéutica para el tratamiento de la piel humana | |
CO6541537A2 (es) | Composición para el cuidado personal que proporciona mejora de suavidad y silencio y articulos usnado la misma | |
BR112013020167A2 (pt) | melhoradores de permeação para formulações tópicas | |
WO2013144260A3 (en) | Composition comprising (2,5-diaminophenyl)ethanol, an alkylpolyglucoside nonionic surfactant, an oxyethylenated sorbitan ester or a polyalkoxylated or polyglycerolated fatty alcohol in a medium rich in fatty substances, dyeing process and device therefore | |
RU2010103038A (ru) | Композиции для персонального ухода, обладающие ослабленным раздражающим действием на глаза | |
PE20110330A1 (es) | Composicion topica para el tratamiento de queratosis actinica | |
PE20151044A1 (es) | Retiro de componentes indeseados de las composiciones de aceite | |
IN2014DN05640A (es) | ||
WO2013004773A3 (en) | Cosmetic composition rich in fatty substances comprising a polyoxyalkylenated fatty alcohol ether and a direct dye and/or an oxidation dye, the dyeing method and the device | |
ES2497667T3 (es) | Sistema de emulsificación para usar en cosméticos | |
BRPI0900822A2 (pt) | composição em forma de emulsão óleo-em-água e processo não terapêutico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |